Hemenway Trust Co LLC boosted its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY – Free Report) by 86.6% in the first quarter, Holdings Channel.com reports. The fund owned 17,981 shares of the company’s stock after buying an additional 8,345 shares during the quarter. Hemenway Trust Co LLC’s holdings in Roche were worth $574,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. First Horizon Advisors Inc. boosted its position in shares of Roche by 19.8% during the fourth quarter. First Horizon Advisors Inc. now owns 2,066 shares of the company’s stock worth $75,000 after purchasing an additional 342 shares in the last quarter. AlphaMark Advisors LLC bought a new position in shares of Roche during the first quarter worth $34,000. Wetzel Investment Advisors Inc. bought a new position in shares of Roche during the fourth quarter worth $53,000. Norman Fields Gottscho Capital Management LLC lifted its position in Roche by 7.3% in the 1st quarter. Norman Fields Gottscho Capital Management LLC now owns 24,100 shares of the company’s stock valued at $769,000 after acquiring an additional 1,650 shares in the last quarter. Finally, Hikari Power Ltd lifted its position in Roche by 0.8% in the 4th quarter. Hikari Power Ltd now owns 237,820 shares of the company’s stock valued at $8,616,000 after acquiring an additional 2,000 shares in the last quarter.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on RHHBY shares. Deutsche Bank Aktiengesellschaft raised shares of Roche from a “sell” rating to a “hold” rating in a research report on Friday, May 17th. The Goldman Sachs Group initiated coverage on shares of Roche in a research report on Thursday, May 30th. They set a “sell” rating on the stock. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $40.00.
Roche Trading Up 1.0 %
OTCMKTS:RHHBY traded up $0.36 on Thursday, hitting $35.16. 586,793 shares of the company’s stock were exchanged, compared to its average volume of 2,489,913. The firm has a 50-day moving average price of $33.09 and a 200-day moving average price of $33.15. The company has a current ratio of 1.35, a quick ratio of 1.04 and a debt-to-equity ratio of 0.75. Roche Holding AG has a 52 week low of $29.20 and a 52 week high of $39.92.
Roche Profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Featured Articles
- Five stocks we like better than Roche
- EV Stocks and How to Profit from Them
- Sales Breakout Sends This Semiconductor Stock to Record High
- Want to Profit on the Downtrend? Downtrends, Explained.
- Surprise Buying Opportunity on This Dividend Aristocrat
- Financial Services Stocks Investing
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY – Free Report).
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.